A compound with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C(Cc3ccc(O)cc3)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)C(Cc3cc4ccccc4[nH]3)n3cc(C(N)C(C)CC)nn3)CC2)n1.Cl has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.323\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C(Cc3ccc(O)cc3)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)C(Cc3cc4ccccc4[nH]3)n3cc(C(N)C(C)CC)nn3)CC2)n1.Cl
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C(Cc3ccc(O)cc3)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)C(Cc3cc4ccccc4[nH]3)n3cc(C(N)C(C)CC)nn3)CC2)n1.Cl
2-[4-(1-amino-3-methylbutyl)triazol-1-yl]-1-[4-[4-[4-[2-[4-(1-amino-2-methylbutyl)triazol-1-yl]-3-(1H-indol-2-yl)propanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-3-(4-hydroxyphenyl)propan-1-one;hydrochloride